Credibility Gap: Toxic Chemicals in Food Packaging
How Green is DuPont's Alternative?
Credibility Gap: Toxic Chemicals in Food Packaging: References
3M. 2008. Information about PFOS and PFOA. Available: http://solutions.3m.com/wps/portal/3M/en_US/PFOS/PFOA/ [accessed June 4 2008].
Andersen ME, Butenhoff JL, Chang SC, Farrar DG, Kennedy GL, Jr., Lau C, et al. 2008. Perfluoroalkyl Acids and Related Chemistries Toxicokinetics and Modes of Action. Toxicol Sci 102(1): 3-14.
Apelberg BJ, Goldman LR, Calafat AM, Herbstman JB, Kuklenyik Z, Heidler J, et al. 2007. Determinants of fetal exposure to polyfluoroalkyl compounds in Baltimore, Maryland. Environ Sci Technol 41(11): 3891-7.
Apelberg BJ, Witter FR, Herbstman JB, Calafat AM, Halden RU, Needham L, et al. 2007. Cord Serum Concentrations of Perfluorooctane Sulfonate (PFOS) and Perfluorooctanoate (PFOA) in Relation to Weight and Size at Birth. Environ Health Perspect 115(11): 1670-6.
Asahi. 2006. Slide presentation by AGC Chemicals, Asahi Glass Co., Ltd., entitled "Non-ECA PFOA Information Forum" at the PFOA Information Forum on June 8, 2006. Document EPA-HQ-OPPT-2003-0012-1094.4.
Asahi Glass Co. 2007. AsahiGuard E-SERIES. Available: http://www.agc.co.jp/english/chemicals/aguard/aguard_1.html [accessed June 4 2008].
Begley TH, White K, Honigfort P, Twaroski ML, Neches R, Walker RA. 2005. Perfluorochemicals: potential sources of and migration from food packaging. Food Addit Contam 22(10): 1023-31.
Biegel LB, Hurtt ME, Frame SR, O'Connor JC, Cook JC. 2001. Mechanisms of extrahepatic tumor induction by peroxisome proliferators in male CD rats. Toxicol Sci 60(1): 44-55.
Biegel LB, Liu RC, Hurtt ME, Cook JC. 1995. Effects of ammonium perfluorooctanoate on Leydig cell function: in vitro, in vivo, and ex vivo studies. Toxicol Appl Pharmacol 134(1): 18-25.
Bookstaff RC, Moore RW, Ingall GB, Peterson RE. 1990. Androgenic deficiency in male rats treated with perfluorodecanoic acid. Toxicol Appl Pharmacol 104(2): 322-33.
Calafat AM, Kuklenyik Z, Reidy JA, Caudill SP, Tully JS, Needham LL. 2007. Serum concentrations of 11 polyfluoroalkyl compounds in the u.s. population: data from the national health and nutrition examination survey (NHANES). Environ Sci Technol 41(7): 2237-42.
Calafat AM, Needham LL, Kuklenyik Z, Reidy JA, Tully JS, Aguilar-Villalobos M, et al. 2006. Perfluorinated chemicals in selected residents of the American continent. Chemosphere 63(3): 490-6.
Calafat AM, Wong LY, Kuklenyik Z, Reidy JA, Needham LL. 2007. Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000. Environ Health Perspect 115(11): 1596-602.
Chye JK, Lim CT. 1999. Very low birth weight infants--mortality and predictive risk factors. Singapore Med J 40(9): 565-70.
Clariant. 2008. Annual Report "Clariant_AR07_e_12_3.pdf" updated 14 April 2008. Available: http://www.clariant.com [accessed June 2 2008].
Conder JM, Hoke RA, De Wolf W, Russell MH, Buck RC. 2008. Are PFCAs bioaccumulative? A critical review and comparison with regulatory criteria and persistent lipophilic compounds. Environ Sci Technol 42(4): 995-1003.
Cook JC, Murray SM, Frame SR, Hurtt ME. 1992. Induction of Leydig cell adenomas by ammonium perfluorooctanoate: a possible endocrine-related mechanism. Toxicol Appl Pharmacol 113(2): 209-17.
Deon JC, Mabury SA. 2007. Production of perfluorinated carboxylic acids (PFCAs) from the biotransformation of polyfluoroalkyl phosphate surfactants (PAPS): exploring routes of human contamination. Environ Sci Technol 41(13): 4799-805.
DeWitt JC, Copeland CB, Strynar MJ, Luebke RW. 2008. Perfluorooctanoic Acid–Induced Immunomodulation in Adult C57BL/6J or C57BL/6N Female Mice. Environ Health Perspect 116(5): 644-50.
DuPont. 1992. Washington Works - surveillance data. Mortality and cancer incidence. US EPA Administrative Record AR226-1546.
DuPont. 2006a. DuPont Participation in Voluntary EPA PFOA Stewardship Program. Available: http://www2.dupont.com/Media_Center/en_BR/news_releases/2006/article20060127c.html [accessed June 5 2008].
DuPont. 2006b. DuPont Concludes Washington Works Employee PFOA Study. DuPont Media Center News Releases: October 17, 2006.
DuPont. 2007a. DuPont Position on PFOA/The Facts about PFOA/Health/Health Effects. Available: http://www2.dupont.com/PFOA/en_US/dupont_position.html [accessed February 27 2008].
DuPont. 2007b. PFOA Facts. Available: http://www2.dupont.com/PFOA/en_US/about_pfoa/pfoa_facts.html [accessed February 27 2008].
DuPont. 2008a. Fact Sheet: DuPontTM CapstoneTM Products for the Paper Packaging Industry. Available: http://www2.dupont.com/Capstone/en_US/index.html [accessed June 4 2008].
DuPont. 2008b. DuPontTM CapstoneTM Press Release. Available: http://www2.dupont.com/Capstone/en_US/index.html [accessed June 4 2008].
DuPont. 2008c. PFOA: Occupational & Public Health. Available: http://www2.dupont.com/PFOA2/en_US/pfoa_human_health.html [accessed June 8 2008].
DuPont's Epidemiology Review Board (ERB). 2005-2006. E-mail communications and memoranda prepared by members of the DuPont's ERB. Filed in the United States District Court - Southern District of West Virginia, Civil Action No. 6:06-cv-00530 (Rhodes, et al. v. E.I.DuPont de Nemours and Company).
Emmett EA, Shofer FS, Zhang H, Freeman D, Desai C, Shaw LM. 2006. Community exposure to perfluorooctanoate: relationships between serum concentrations and exposure sources. J Occup Environ Med 48(8): 759-70.
Environmental Working Group (EWG). 2004. Update to EWG petition to EPA concerning DuPont's response to EPA's inquiry of possible TSCA Section 8(e) substantial risk reporting violations. Available: https://www.ewg.org/node/21308 [accessed June 6 2008].
EWG. 2005. Environmental Working Group Human Toxome Project: PFHxA (Perfluorohexanoic acid). Available: https://www.ewg.org/sites/humantoxome/chemicals/chemical.php?chemid=100304 [accessed May 26 2008].
Fairley KJ, Purdy R, Kearns S, Anderson SE, Meade B. 2007. Exposure to the Immunosuppresant, Perfluorooctanoic Acid, Enhances the Murine IgE and Airway Hyperreactivity Response to Ovalbumin. Toxicol Sci 97(2): 375-83.
FDA. 1969. Division of Pharmacology and Toxicology. Memorandum. Food Additive Petition No. 0B2434 (Evaluation of 7/1/69 submission) 3M Company.
FDA. 2006. Division of Food Contact Notifications Toxicology Group. Memorandum. FCN 599. Final Toxicology memorandum: Use of copolymer of polyfluorooctyl methacrylate, 2-N,N-diethylaminoethylmethacrylate, 2-hydroxyethylmethacrylate, and 2,2’-ethylenedioxydiethyldimethacrylate as an oil, grease, and water resistant treatment for paper and paperboard employed either prior to the sheet forming operation or at the size press.
FDA. 2008. Food and Drug Administration Center for Food Safety and Applied Nutrition Office of Food Additive Safety: Inventory of Effective Food Contact Substance (FCS) Notifications. Available: http://www.cfsan.fda.gov/~dms/opa-fcn.html [accessed June 4 2008].
Fei C, McLaughlin JK, Tarone RE, Olsen J. 2007. Perfluorinated Chemicals and Fetal Growth: A Study within the Danish National Birth Cohort. Environmental Health Perspectives 115(11): 1677-82.
Fenton SE, Lau C, Hines EP, Thibodeaux JR, White SS. 2007. Long-term health effects of PFOA after prenatal and lactational exposure in mice. Toxicologist 96: 12.
Frisbee S. 2008. The C8 Health Project: How a Class Action Lawsuit Can Interact with Public Health - History of Events. Available: http://www.hsc.wvu.edu/som/cmed/ophp/grandRoundsWebcast.asp [accessed May 12 2008].
Gilliland FD, Mandel JS. 1993. Mortality among employees of a perfluorooctanoic acid production plant. J Occup Med 35(9): 950-4.
Guruge KS, Yeung LW, Yamanaka N, Miyazaki S, Lam PK, Giesy JP, et al. 2006. Gene expression profiles in rat liver treated with perfluorooctanoic acid (PFOA). Toxicol Sci 89(1): 93-107.
Houde M, Martin JW, Letcher RJ, Solomon KR, Muir DC. 2006. Biological monitoring of polyfluoroalkyl substances: A review. Environ Sci Technol 40(11): 3463-73.
Inoue K, Okada F, Ito R, Kawaguchi M, Okanouchi N, Nakazawa H. 2004. Determination of perfluorooctane sulfonate, perfluorooctanoate and perfluorooctane sulfonylamide in human plasma by column-switching liquid chromatography-electrospray mass spectrometry coupled with solid-phase extraction. J Chromatogr B Analyt Technol Biomed Life Sci 810(1): 49-56.
Jin Y, Saito N, Harada KH, Inoue K, Koizumi A. 2007. Historical trends in human serum levels of perfluorooctanoate and perfluorooctane sulfonate in Shenyang, China. Tohoku J Exp Med 212(1): 63-70.
Johansson N, Fredriksson A, Eriksson P. 2008. Neonatal exposure to perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) causes neurobehavioural defects in adult mice. Neurotoxicology 29(1): 160-9.
Joyce JM. 2007. Ahlstrom Windsor Locks LLC FYI-0407-01539B TSCA 8(e) submittal to US EPA Office of Pollution Prevention and Toxics. Available: http://www.epa.gov/oppt/tsca8e/pubs/8emonthlyreports/2007/8eapr2007.htm [accessed May 12 2008].
Kannan K, Corsolini S, Falandysz J, Fillmann G, Kumar KS, Loganathan BG, et al. 2004. Perfluorooctanesulfonate and related fluorochemicals in human blood from several countries. Environ Sci Technol 38(17): 4489-95.
Kannan K, Corsolini S, Falandysz J, Oehme G, Focardi S, Giesy JP. 2002. Perfluorooctanesulfonate and related fluorinated hydrocarbons in marine mammals, fishes, and birds from coasts of the Baltic and the Mediterranean Seas. Environ Sci Technol 36(15): 3210-6.
Karrman A, Ericson I, van Bavel B, Darnerud PO, Aune M, Glynn A, et al. 2007. Exposure of perfluorinated chemicals through lactation: levels of matched human milk and serum and a temporal trend, 1996-2004, in Sweden. Environ Health Perspect 115(2): 226-30.
Keil DE, Mehlmann T, Butterworth L, Peden-Adams MM. 2008. Gestational exposure to perfluorooctane sulfonate suppresses immune function in B6C3F1 mice. Toxicol Sci 103(1): 77-85.
Kuklenyik Z, Reich JA, Tully JS, Needham LL, Calafat AM. 2004. Automated solid-phase extraction and measurement of perfluorinated organic acids and amides in human serum and milk. Environ Sci Technol 38(13): 3698-704.
Lau C, Anitole K, Hodes C, Lai D, Pfahles-Hutchens A, Seed J. 2007. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol Sci 99(2): 366-94.
Lau C, Butenhoff JL, Rogers JM. 2004. The developmental toxicity of perfluoroalkyl acids and their derivatives. Toxicol Appl Pharmacol 198(2): 231-41.
Lau C, Rogers JM. 2004. Embryonic and fetal programming of physiological disorders in adulthood. Birth Defects Res C Embryo Today 72(4): 300-12.
Lau C, Thibodeaux JR, Hanson RG, Rogers JM, Grey BE, Stanton ME, et al. 2003. Exposure to Perfluorooctane Sulfonate During Pregnancy in Rat and Mouse. II. Postnatal Evaluation. Toxicol Sci 4(2): 382-92.
Lawyer AL. 2008. Testimony by Arthur L. Lawyer, Vice President, Technology Sciences Group, Inc.. April 23, 2008. California State Senate Health Committee. Available: www.calchannel.com/search.php?date=042308&source=senate&type=committee&title=&Search=Submit [accessed May 2 2008]
Leonard RC, Kreckmann KH, Sakr CJ, Symons JM. 2007. Retrospective Cohort Mortality Study of Workers in a Polymer Production Plant Including a Reference Population of Regional Workers. Ann Epidemiol 18(1): 15-22.
Liu RC, Hurtt ME, Cook JC, Biegel LB. 1996. Effect of the peroxisome proliferator, ammonium perfluorooctanoate (C8), on hepatic aromatase activity in adult male Crl:CD BR (CD) rats. Fundam Appl Toxicol 30(2): 220-8.
Lundin JI, Alexander BH. 2007. Mortality of Employees of an Ammonium Perfluorooctanoate Production facility. Final Report to US EPA Office of Pollution Prevention and Toxics (OPPT) Docket No AR-226.
Martin JW, Mabury SA, Solomon KR, Muir DC. 2003. Bioconcentration and tissue distribution of perfluorinated acids in rainbow trout (Oncorhynchus mykiss). Environ Toxicol Chem 22(1): 196-204.
Martin MT, Brennan RJ, Hu W, Ayanoglu E, Lau C, Ren H, et al. 2007. Toxicogenomic study of triazole fungicides and perfluoroalkyl acids in rat livers predicts toxicity and categorizes chemicals based on mechanisms of toxicity. Toxicol Sci 97(2): 595-613.
Matte TD, Bresnahan M, Begg MD, Susser E. 2001. Influence of variation in birth weight within normal range and within sibships on IQ at age 7 years: cohort study. British Medical Journal (BMJ) 323(7308): 310-4.
MDH. 2008. Minnesota Department of Health: Perfluorochemicals in Minnesota. Available: http://www.health.state.mn.us/divs/eh/hazardous/topics/pfcs/index.html [accessed May 20 2008].
Midasch O, Drexler H, Hart N, Beckmann MW, Angerer J. 2007. Transplacental exposure of neonates to perfluorooctanesulfonate and perfluorooctanoate: a pilot study. Int Arch Occup Environ Health 80(7): 643-8.
Nanowerk. 2008. NanoSphere At The Cutting Edge. Available: http://www.nanowerk.com/news/newsid=5727.php [accessed June 2 2008].
NAS. 1972. National Academy of Sciences: Degradation of synthetic organic molecules in the biosphere.
Needham LL, Calafat AM, Barr DB. 2008. Assessing developmental toxicant exposures via biomonitoring. Basic Clin Pharmacol Toxicol 102(2): 100-8.
Olsen GW, Gilliland FD, Burlew MM, Burris JM, Mandel JS, Mandel JH. 1998. An epidemiologic investigation of reproductive hormones in men with occupational exposure to perfluorooctanoic acid. J Occup Environ Med 40(7): 614-22.
Olsen GW, Burlew MM, Marshall JC, Burris JM, Mandel JH. 2004. Analysis of episodes of care in a perfluorooctanesulfonyl fluoride production facility. J Occup Environ Med 46(8): 837-46.
Olsen GW, Burris JM, Burlew MM, Mandel JH. 2003. Epidemiologic assessment of worker serum perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations and medical surveillance examinations. J Occup Environ Med 45(3): 260-70.
Olsen GW, Burris JM, Ehresman DJ, Froehlich JW, Seacat AM, Butenhoff JL, et al. 2007. Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ Health Perspect 115(9): 1298-305.
Olsen GW, Church TR, Hansen KJ, Burris JM, Butenhoff JL, Mandel JH, et al. 2004. Quantitative Evaluation of Perfluorooctanesulfonate (PFOS) and Other Fluorochemicals in the Serum of Children. Journal of Children's Health 2(1): 53-76.
Olsen GW, Mair DC, Church TR, Ellefso ME, Reagen WK, Boyd TM, et al. 2008. Decline in Perfluorooctanesulfonate and Other Polyfluoroalkyl Chemicals in American Red Cross Adult Blood Donors, 2000?2006. Environ Sci Technol: in press.
Olsen GW, Zobel LR. 2007. Assessment of lipid, hepatic, and thyroid parameters with serum perfluorooctanoate (PFOA) concentrations in fluorochemical production workers. Int Arch Occup Environ Health 81(2): 231-46.
Packaging Expo. 2008. About Packaging - The Market. Available: http://www.packagingexpo.com.cn/EN/second.asp?id=0102 [accessed June 6 2008].
Peden-Adams MM, Keller JM, Eudaly JG, Berger J, Gilkeson GS, Keil DE. 2008. Suppression of Humoral Immunity in Mice Following Exposure to Perfluorooctane Sulfonate (PFOS). Toxicol Sci: in press.
Prevedouros K, Cousins IT, Buck RC, Korzeniowski SH. 2006. Sources, fate and transport of perfluorocarboxylates. Environ Sci Technol 40(1): 32-44.
Rosen MB, Thibodeaux JR, Wood CR, Zehr RD, Schmid JE, Lau C. 2007. Gene expression profiling in the lung and liver of PFOA-exposed mouse fetuses. Toxicology 239(1-2): 15-33.
SAB. 2006. US EPA Science Advisory Board Review of EPA's Draft Risk Assessment of Potential Human Health Effects Associated with PFOA and Its Salts. EPA-SAB-06-006; Washington, DC, 2006.
Sakr CJ, Kreckmann KH, Green JW, Gillies PJ, Reynolds JL, Leonard RC. 2007. Cross-sectional study of lipids and liver enzymes related to a serum biomarker of exposure (ammonium perfluorooctanoate or APFO) as part of a general health survey in a cohort of occupationally exposed workers. J Occup Environ Med 49(10): 1086-96.
Sakr CJ, Leonard RC, Kreckmann KH, Slade MD, Cullen MR. 2007. Longitudinal study of serum lipids and liver enzymes in workers with occupational exposure to ammonium perfluorooctanoate. J Occup Environ Med 49(8): 872-9.
Sanitized AG. 2008. New generation of fluorocarbons based on C6 chemistry. Available: http://www.sanitized.com/en/about-us/news-events/article/1/herausragend.html [accessed June 2 2008].
Sauve RS, Robertson C, Etches P, Byrne PJ, Dayer-Zamora V. 1998. Before viability: a geographically based outcome study of infants weighing 500 grams or less at birth. Pediatrics 101(3 Pt 1): 438-45.
Sibinski LJ. 1987. Two-Year oral (diet) toxicity/carcinogenicity study of fluorochemical FC-143 (perfluorooctane ammonium carboxylate) in rats. Report prepared for 3M, St Paul, Minnesota by Riker Laboratories Inc Study No 0281CR0012; 8EHQ-1087-0394, October 16, 1987 Reviewed in US EPA "Revised Draft PFOA Hazard Assessment-Robust Study Annex" AR226-1137, (pp. 260-267; PDF pp 157-164).
Sinclair E, Kim SK, Akinleye HB, Kannan K. 2007. Quantitation of Gas-Phase Perfluoroalkyl Surfactants and Fluorotelomer Alcohols Released from Nonstick Cookware and Microwave Popcorn Bags. Environ Sci Technol 41(4): 1180-5.
Sinclair E, Mayack DT, Roblee K, Yamashita N, Kannan K. 2006. Occurrence of perfluoroalkyl surfactants in water, fish, and birds from New York State. Arch Environ Contam Toxicol 50(3): 398-410.
So MK, Yamashita N, Taniyasu S, Jiang Q, Giesy JP, Chen K, et al. 2006. Health risks in infants associated with exposure to perfluorinated compounds in human breast milk from Zhoushan, China. Environ Sci Technol 40(9): 2924-9.
Son HY, Kim SH, Shin HI, Bae HI, Yang JH. 2007. Perfluorooctanoic acid-induced hepatic toxicity following 21-day oral exposure in mice. Arch Toxicol 82(4): 239-46.
Tao L, Kannan K, Wong CM, Arcard KF, Butenhoff JL. 2008. Perfluorinated Compounds in Human Milk from Massachusetts, U.S.A. Environ Sci Technol 42: 3096-101.
Tittlemier SA, Pepper K, Seymour C, Moisey J, Bronson R, Cao XL, et al. 2007. Dietary exposure of Canadians to perfluorinated carboxylates and perfluorooctane sulfonate via consumption of meat, fish, fast foods, and food items prepared in their packaging. J Agric Food Chem 55(8): 3203-10.
Tittlemier SA, Ryan JJ, Van Oostdam J. 2004. Presence of anionic organic compounds in serum collected from northern Canadian populations. In: Organohalogen Compounds, 4009-14.
US Environmental Protection Agency (US EPA). 2004. EPA Takes Enforcement Action against DuPont for Toxic Substances Reporting Violations [Press Release]. Available: http://yosemite.epa.gov/opa/admpress.nsf/f2812c1a8484b3b5852572a000650c02/afdc5785fd9ee05585256ecb00522cee!OpenDocument [accessed 27 December 2007].
US EPA. 2005. EPA Settles PFOA Case Against DuPont for Largest Environmental Administrative Penalty in Agency History. Available: http://yosemite.epa.gov/opa/admpress.nsf/68b5f2d54f3eefd28525701500517fbf/fdcb2f665cac66bb852570d7005d6665!OpenDocument [accessed June 5 2008].
US EPA. 2006a. 2010/15 PFOA Stewardship Program. Available: http://www.epa.gov/oppt/pfoa/pubs/pfoastewardship.htm [accessed 27 December 2007].
US EPA. 2006b. Fact Sheet: EPA, DuPont Agree on Measures to Protect Drinking Water Near the DuPont Washington Works. Available: http://www.epa.gov/region03/enforcement/dupont_factsheet.html [accessed December 28 2007].
US EPA. 2008. Toxic Substance Control Act (TSCA) Section 8(e) Notices. Available: http://www.epa.gov/oppt/tsca8e/index.htm [accessed June 3 2008].
Volkel W, Genzel-Boroviczeny O, Demmelmair H, Gebauer C, Koletzko B, Twardella D, et al. 2007. Perfluorooctane sulphonate (PFOS) and perfluorooctanoic acid (PFOA) in human breast milk: Results of a pilot study. Int J Hyg Environ Health: in press.
West Virginia University School of Medicine. 2008. The C8 Health Project: WVU Data Housing Website. Available: http://www.hsc.wvu.edu/som/cmed/c8/ [accessed May 12 2008].
White SS, Calafat AM, Kuklenyik Z, Villanueva L, Zehr RD, Helfant L, et al. 2007. Gestational PFOA exposure of mice is associated with altered mammary gland development in dams and female offspring. Toxicol Sci 96(1): 133-44.
Wolf CJ, Fenton SE, Schmid JE, Calafat AM, Kuklenyik Z, Bryant XA, et al. 2007. Developmental toxicity of perfluorooctanoic acid in the CD-1 mouse after cross-foster and restricted gestational exposures. Toxicol Sci 95(2): 462-73.
Yang Q, Abedi-Valugerdi M, Xie Y, Zhao XY, Moller G, Nelson BD, et al. 2002. Potent suppression of the adaptive immune response in mice upon dietary exposure to the potent peroxisome proliferator, perfluorooctanoic acid. Int Immunopharmacol 2(2-3): 389-97.
Yang Q, Xie Y, Depierre JW. 2000. Effects of peroxisome proliferators on the thymus and spleen of mice. Clin Exp Immunol 122(2): 219-26.
Yeung LW, Guruge KS, Yamanaka N, Miyazaki S, Lam PK. 2007. Differential expression of chicken hepatic genes responsive to PFOA and PFOS. Toxicology 237(1-3): 111-25.